SunBio Inc. is a biotech company engaged in the development of biosimilars, biopharmaceuticals, and medical devices, leveraging its proprietary pegylation technologies. The company has established itself as a key player in the pharmaceutical industry, offering a range of high-quality PEG products and derivatives essential for the art of PEGylation. SunBio’s manufacturing facility, which is approved by the EMA for GMP production, is operational and supports the company’s commitment to delivering premium biopharmaceutical products. The company’s notable biosimilar, PEG-filgrastim, has been marketed in the EU as Pelgraz™, in Canada as Lapelga™, and in India as NeuPEG™.

Services include:
– APIs (Active Pharmaceutical Ingredients)
– Biologics
– Biosimilars
– Medical Devices
– PEG Products
– PEG Derivatives

SunBio Inc. stands out for its innovative contributions to the biopharmaceutical landscape, ensuring the availability of vital products for the pharmaceutical industry. For further details, visit sunbio.com.